Every year, thousands of medical devices and drugs are recalled in the US. But the decision to recall a flawed product is often left up to the manufacturer.
OxyContin maker Purdue has reportedly been mulling a bankruptcy filling, just as the first of around 2,000 lawsuits against it prepares to go to trial.
Jonathan S. Jones, Binghamton University, State University of New York
Considered in historical context, Purdue’s plan to peddle opioid addiction medicines to vulnerable people is not so surprising. Gilded-Age pharmaceutical companies used similar strategies.
A new study reveals how many patient groups lobby for new drugs to be funded by public plans in Canada – all while receiving funding from the companies manufacturing the drugs in question.
Clinical guidelines have a big impact on the care you receive and the drugs you’re prescribed. But one in five doctors who write these guidelines have undisclosed ties to drug companies.
Developing drugs is typically the domain of large pharmaceutical companies. But here is an example of drug development for a rare pediatric brain cancer that was done in a university setting.
Sarah Giles, L’Université d’Ottawa/University of Ottawa
This week’s annual Family Medicine Forum is an opportunity for your family doctor – to cave or resist in the face of Big Pharma sponsorship and marketing.
Noted physician and author Atul Gawande was named CEO of a new health care venture aimed at cutting costs and improving care. But the most important man to keep an eye on in this effort isn’t Gawande. It’s the middleman.
The logic behind U.S. president Donald Trump’s proposal that Canada and other countries have been “free-riding” off high prices in the United States is bizarre at best.
Drug prices in Australia are three times higher than in New Zealand. A key reason is the lack of transparency about taxpayer subsidies for Big Pharma and the companies’ own finances.
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney